Terms: = Head and neck cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257
2150 results:
1. Fusobacterium periodonticum BCT protein targeting glucose metabolism to promote the epithelial-mesenchymal transition of esophageal cancer cells by lactic acid.
Guo X; Wan P; Shen W; Sun M; Peng Z; Liao Y; Huang Y; Liu R
J Transl Med; 2024 Apr; 22(1):401. PubMed ID: 38689341
[TBL] [Abstract] [Full Text] [Related]
2. Characterization of macrophages in head and neck squamous cell carcinoma and development of MRG-based risk signature.
Liu L; Liu Q
Sci Rep; 2024 Apr; 14(1):9914. PubMed ID: 38688945
[TBL] [Abstract] [Full Text] [Related]
3. Biological functions of LncRNA SNHG14 in the development of thyroid cancer cells via targeting miR-206.
Sang Y; Min R; Huang T; Zhang J
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):77-84. PubMed ID: 38678623
[TBL] [Abstract] [Full Text] [Related]
4. Annexin A2 combined with TTK accelerates esophageal cancer progression via the Akt/mTOR signaling pathway.
Liu R; Lu Y; Li J; Yao W; Wu J; Chen X; Huang L; Nan D; Zhang Y; Chen W; Wang Y; Jia Y; Tang J; Liang X; Zhang H
Cell Death Dis; 2024 Apr; 15(4):291. PubMed ID: 38658569
[TBL] [Abstract] [Full Text] [Related]
5. Lactoferrin mediates epithelial-mesenchymal transformation by regulating the PI3K/AKT/mTOR pathway to inhibit nasopharyngeal carcinoma metastasis.
Xu M; Fan Y; Zou G; Yang Q; Xu F
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):130-135. PubMed ID: 38650146
[TBL] [Abstract] [Full Text] [Related]
6. SLC2A3 promotes tumor progression through lactic acid-promoted TGF-β signaling pathway in oral squamous cell carcinoma.
Jiang W; Xu S; Li P
PLoS One; 2024; 19(4):e0301724. PubMed ID: 38625978
[TBL] [Abstract] [Full Text] [Related]
7. Biomarker Potential of
Ju Y; Zhu F; Fang B
Int J Med Sci; 2024; 21(5):921-936. PubMed ID: 38617010
[TBL] [Abstract] [Full Text] [Related]
8. The circadian clock gene, BMAL1, promotes radiosensitization in nasopharyngeal carcinoma by inhibiting the epithelial-to-mesenchymal transition via the TGF-β1/Smads/Snail1 axis.
Li Y; Zhou Y; Zhao C; Liu L; He Q; Shang K; Xu X; Luo X; Zhou D; Jin F
Oral Oncol; 2024 May; 152():106798. PubMed ID: 38615583
[TBL] [Abstract] [Full Text] [Related]
9. Polycomb repressive complex 2 and its core component EZH2: potential targeted therapeutic strategies for head and neck squamous cell carcinoma.
Cheng Y; Song Z; Fang X; Tang Z
Clin Epigenetics; 2024 Apr; 16(1):54. PubMed ID: 38600608
[TBL] [Abstract] [Full Text] [Related]
10. DNMT1-mediated epigenetic suppression of FBXO32 expression promoting cyclin dependent kinase 9 (CDK9) survival and esophageal cancer cell growth.
Song XQ; Chen BB; Jin YM; Wang CY
Cell Cycle; 2024 Feb; 23(3):262-278. PubMed ID: 38597826
[TBL] [Abstract] [Full Text] [Related]
11. Integrative analysis reveals associations between oral microbiota dysbiosis and host genetic and epigenetic aberrations in oral cavity squamous cell carcinoma.
Cai L; Zhu H; Mou Q; Wong PY; Lan L; Ng CWK; Lei P; Cheung MK; Wang D; Wong EWY; Lau EHL; Yeung ZWC; Lai R; Meehan K; Fung S; Chan KCA; Lui VWY; Cheng ASL; Yu J; Chan PKS; Chan JYK; Chen Z
NPJ Biofilms Microbiomes; 2024 Apr; 10(1):39. PubMed ID: 38589501
[TBL] [Abstract] [Full Text] [Related]
12. [Downregulation of SETDB1 suppresses epithelial mesenchymal transition and invasion and metastasis in oral cancer via SOX7 methylation].
Hao Y; Bai XY; Huo F; Chen XB
Shanghai Kou Qiang Yi Xue; 2024 Feb; 33(1):30-35. PubMed ID: 38583021
[TBL] [Abstract] [Full Text] [Related]
13. ADAM22 acts as a novel predictive biomarker for unfavorable prognosis and facilitates metastasis via PI3K/AKT signaling pathway in nasopharyngeal carcinoma.
Xu K; Jiang P; Chen Z; Gu X; Zhang T
Pathol Res Pract; 2024 Apr; 256():155264. PubMed ID: 38518731
[TBL] [Abstract] [Full Text] [Related]
14. Involvement of TGFBI-TAGLN axis in cancer stem cell property of head and neck squamous cell carcinoma.
Sarubo M; Mouri Y; Moromizato A; Yamada A; Jin S; Shao W; Hagita H; Miyoshi K; Kudo Y
Sci Rep; 2024 Mar; 14(1):6767. PubMed ID: 38514830
[TBL] [Abstract] [Full Text] [Related]
15. c-MET pathway in human malignancies and its targeting by natural compounds for cancer therapy.
Mohan CD; Shanmugam MK; Gowda SGS; Chinnathambi A; Rangappa KS; Sethi G
Phytomedicine; 2024 Jun; 128():155379. PubMed ID: 38503157
[TBL] [Abstract] [Full Text] [Related]
16. MYB/LINC00092 regulatory axis promotes the progression of papillary thyroid carcinoma.
Cheng L; Deng X; Le Y
Endokrynol Pol; 2024; 75(1):27-34. PubMed ID: 38497387
[TBL] [Abstract] [Full Text] [Related]
17. [Expression and clinical significance of NEK2 and emt related molecules in oral squamous cell carcinoma].
Ye TT; Chen WH; Pei J; Jia YX; Wu HY
Shanghai Kou Qiang Yi Xue; 2023 Dec; 32(6):640-644. PubMed ID: 38494974
[TBL] [Abstract] [Full Text] [Related]
18. [Inhibitory effect of paeoniflorin on CAL27 cells of tongue squamous cell carcinoma and its mechanism].
Liu Y; Chen HY; Mi J; Wang FF; Wan GY; Cui C
Shanghai Kou Qiang Yi Xue; 2023 Dec; 32(6):597-602. PubMed ID: 38494967
[TBL] [Abstract] [Full Text] [Related]
19. Nicotine downregulates miR-375-3p via neurotrophic tyrosine receptor kinase 2 to enhance the malignant behaviors of laryngopharyngeal squamous epithelial cells.
Shen YJ; Ji MY; Huang Q; Hsueh CY; Du HD; Zhang M; Zhou L
Ecotoxicol Environ Saf; 2024 Apr; 274():116215. PubMed ID: 38489902
[TBL] [Abstract] [Full Text] [Related]
20. In vitro antimetastatic potential of pseudolaric acid B in HSC-3 human tongue squamous carcinoma cell line.
Yu HJ; Kim JH; Choi SJ; Cho SD
Arch Oral Biol; 2024 Jun; 162():105940. PubMed ID: 38479277
[TBL] [Abstract] [Full Text] [Related]
[Next]
